Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment
Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Attacks of hereditary angioedema (HAE) are unpredictable and, if affecting the upper airway, can be lethal. Icatibant is used for physician- or patient self-administered symptomatic treatment of HAE attacks in adults. Its mode of action includes disruption of the bradykinin pathway via blockade of the bradykinin B(2) receptor. Early treatment is be...
Alternative Titles
Full title
Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1339960555
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1339960555
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0053773
